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ANNOUNCEMENT 
The Third Dermatopathology Self Assessment Workshop will be held September 17 -19, 
1992 in Rome, Italy, with AB Ackerman (New York University, USA), E. Wilson-Jones 
(London University, UK), and R. Cerio (Royal London Hospital, UK). 
The workshop will provide an in-depth review of difficult topics in dermatopathology: 
malignant melanoma (AB Ackerman), vascular tumors (E. Wilson Jones), and immunohisto-
chemistry applied to dermatopathology (R. Cerio). 
The program will consist of a series of lectures and of a direct examination of slides. Micro-
scopes will be provided for the participants. The course fee is US $200 for participation in all the 
activities of the course or US $ 1 00 for those desmng to attend the lectures only. 
For further information please contact Guido Massi, MD, Department of Pathology, Catho-
lic University, Largo F. Vito, 1,00168 Rome, Italy; tel, (6) 3303481/30154270/5759733; fax, 
(6) 3051343. 
